Inhibition of human airway sensitization by a novel monoclonal anti-IgE antibody, 17-9

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 5 PART I, 1998, Pages 1429-1435

  Rabe, Klaus F ^b   Watson, Nikki ^a   Dent, Gordon ^c   Morton, Benita E ^c   Wagner, Kathrin ^c   Magnussen, Helgo ^c   Heusser, Christoph H ^c  

^a ROCHE BIOSCIENCE   (United States)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY 17 9; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ARTICLE; ATOPY; BRONCHUS HYPERREACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HISTAMINE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSITIZATION;

AGED; ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, DERMATOPHAGOIDES; BRONCHI; BRONCHOCONSTRICTION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GLYCOPROTEINS; HISTAMINE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MALE; MICE; MIDDLE AGED;

EID: 0031746879     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.5.9708127     Document Type: Article

References (17)

1. Dunlop, L. S., and A. P. Smith. 1975. Reduction of antigen-induced contraction of sensitized human bronchus in vitro by indomethacin. Br. J. Pharmacol. 54:495-197.
2. Creese, B. R., and D. M. Temple. 19S6. The mediators of allergic contraction of human airway smooth muscle: a comparison of bronchial and lung parenchymal strip preparations. Clin. Exp. Pharmacol. Physiol. 13:103-111.
3. Roberts, J. A., and N. C. Thomson. 1989. The effect of passive sensitisation of human bronchial smooth muscle on in vitro sensitivity to histamine. Pulm. Pharmacol. 2:103-105.
4. Björck, T., Y. Harada, B. Dahlén, O. Zetterström, G. Johansson, L. Rodriguez, P. Hedqvist, and S.-E. Dahlén. 1990. Further evidence that leukotrienes are the major mediators of allergic constriction in human bronchi. Adv. Prost. Thromb. Leuk. Res. 21:429-432.
5. Davis, C., T. R. Jones, and E. E. Daniel. 1983. Studies of the mechanism of passive anaphylaxis in human airway smooth muscle. Can. J. Physiol. Pharmacol. 61:705-713.
6. Tunon de Lara, J. M., Y. Okayama, J.-P. Savineau, and R. Marthan. 1995. IgE-induced passive sensitization of human isolated bronchi and lung mast cells. Eur. Respir. J. 8:1861-1865.
7. Schild, H. O., D. F. Hawkins, J. L. Mongar, and H. Herxheimer. 1951. Reactions of isolated human asthmatic lung and bronchial tissue to a specific antigen: histamine release and muscular contraction. Lancet 1:376-382.
8. Black, J. L., R. Marthan, C. L. Armour, and P. R. A. Johnson. 1989. Sensitization alters contractile responses and calcium influx in human airway smooth muscle. J. Allergy Clin. Immunol. 84:440-447.
9. Marthan, R., H. Crevel, H. Guénard, and J.-P. Savineau. 1992. Responsiveness to histamine of human sensitized airway smooth muscle. Respir. Physiol 90:1706-1714.
10. Ben-Jebria, A., R. Marthan, M. Rossetti, and J.-P. Savineau. 1993. Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br. J. Pharmacol. 109:131-136.
11. 4 and antigen in vitro. Am. Rev. Respir. Dis. 146:923-929.
12. Malo, P. E., R. L. Bell, T. K. Shaughnessy, J. B. Summers, D. W. Brooks, and G. W. Carter. 1994. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis. Pulm. Pharmacol. 7:73-79.
13. Watson, N., K. Bodtke, R. A. Coleman, G. Dent, B. E. Morton, E. Rühlmann, H. Magnussen, and K. F. Rabe. 1997. Role of IgE in hyperresponsiveness induced by passive sensitization of human airways. Am. J. Respir. Crit. Care Med. 155:839-844.
14. Pride, N. B., R. G. Taylor, T. K. Lim, H. Joyce, and A. Watson. 1987. Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull. Eur. Physiopathol. Respir. 23:369-375.
15. Empey, D. W., L. A. Laitinen, L. Jacobs, W. M. Gold, and J. A. Nadel. 1976. Mechanism of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am. Rev. Respir. Dis. 113:131-139.
16. Neuberger, M. S., G. T. Williams, E. B. Mitchell, S. S. Jouhal, J. G. Flanagan, and T: H. Rabbitts. 1985. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 314:268-270.
17. Rabe, K. F., B. E. Morton, G. Dent, N. M. Muñoz, K. Wagner, A. R. Leff, H. Magnussen, and C. H. Heusser. 1995. Inhibition of allergen-induced contraction of human airways in vitro by a monoclonal anti-human IgE antibody (abstract). Am. J. Respir. Crit. Care Med. 151:A215.